China Threatens to Cut Off Medicine, Throw America into ‘Mighty Sea of Coronavirus’

One of the insults harped on by Xinhua was Walter Russell Mead’s February 3 op-ed for the Wall Street Journal entitled “China Is the Real Sick Man of Asia,” a piece that prompted Beijing to expel Wall Street Journal reporters and begin complaining incessantly that Mead’s piece was insulting and racist. According to Xinhua’s March 4 editorial, Mead, his column, and the entire Wall Street Journal publication are now “infamous.”

Although most commentary has focused on the “mighty sea of coronavirus” threat, the Xinhua piece is also interesting as an early example of the Chinese Communist propaganda crusade to portray the coronavirus as originating in the United States and claim it was brought to Wuhan by the U.S. Army. Xinhua muttered darkly on March 4 about Americans “returning from Wuhan, China” right before the outbreak exploded and complained it was therefore hypocritical and insulting for the U.S. to impose travel bans on China.

The article was noticed and partially translated by Fox News on Friday in light of the Food and Drug Administration’s announcement that at least one unspecified drug useful for treating coronavirus patients is currently in short supply because the components for the drug cannot be obtained readily enough from China.

“In other words, they threatened to kill us, and we’re all sort of standing back like, ‘Oh, you know it’s not a big deal.’ It’s a terrifying situation,” Tucker Carlson of Fox News said on Wednesday.

Sen. Marco Rubio (R-FL) warned in a Fox News interview on Thursday that “about 80 percent of the active ingredients” in some vital drugs come from abroad, “and the overwhelming majority of that 80 percent are manufactured in China.”

Rubio and former House Speaker Newt Gingrich elaborated on China’s leverage over the U.S. pharmaceutical industry, and other sectors of the American economy, in an op-ed for Fox:

For years, China has enticed American multinational corporations with access to its markets in exchange for off-shoring and sharing intellectual property. Americans watched as Beijing captured critical portions of global supply chains, including in pharmaceutical drugs and medical equipment. Today, up to 80 percent of the active pharmaceutical ingredients in American drugs are sourced abroad.

Now, in the face of a pandemic, the absence of domestic capacity in critical medical sectors has critically endangered both the U.S. public health system and our economy. The inability to quickly increase the production of key supplies, such as surgical masks, medical gowns, respirators and pharmaceutical drugs limits our ability to mitigate the worst effects of the disease in this emerging crisis and in any future pandemic.

It is unacceptable that China holds this much leverage over America’s public health and economy, both essential components of our national security. For this reason, we propose that the U.S. take action to expand our production capacity while global supply chains are in flux and the global economy teeters on the edge of recession.

Rubio and Gingrich suggested encouraging and incentivizing American corporations to bring manufacturing capacity back from overseas, especially from hostile areas like China, taking advantage of the current chaos in global markets to implement measures that might have seemed unacceptably risky or painful in calmer times.

“America must make rebuilding our domestic supply chain a priority of its own,” they wrote, comparing their recommendations to Beijing’s deliberate strategy for capturing the biomedical industry.

Story cited here.

Share this article:

Facebook

Twitter